AngioDynamics, Inc. (ANGO) is a publicly traded Healthcare sector company. As of November 18, 2026, ANGO trades at $11.32 with a market cap of $483.21M and a P/E ratio of -17.18. ANGO moved -1.48% today. Year to date, ANGO is -14.44%; over the trailing twelve months it is -4.72%. Its 52-week range spans $8.36 to $16.29. Analyst consensus is buy with an average price target of $19.00. Rallies surfaces ANGO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for ANGO, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $11.32 |
| Market Cap | $483.21M |
| P/E Ratio | -17.18 |
| EPS | $-0.88 |
| Dividend Yield | 0.00% |
| 52-Week High | $16.29 |
| 52-Week Low | $8.36 |
| Volume | 275.36K |
| Avg Volume | 0 |
| Revenue (TTM) | $320.17M |
| Net Income | $-36.74M |
| Gross Margin | 54.62% |
2 analysts cover ANGO: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $19.00.